Literature DB >> 7926527

The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism.

C C McGowan1, T L Cover, M J Blaser.   

Abstract

BACKGROUND/AIMS: Omeprazole, a benzimidazole proton pump inhibitor, has an antibacterial effect against Helicobacter pylori at neutral pH and inhibits its urease activity. The aim of this study was to characterize H. pylori acid resistance and to determine whether omeprazole effects its survival at low pH.
METHODS: We studied survival of H. pylori and other enteric organisms in buffered solutions (pH 2-7) in the presence or absence of 10 mmol/L urea and/or omeprazole.
RESULTS: In the absence of urea, the acid tolerances of wild-type H. pylori, a urease-negative H. pylori mutant, Escherichia coli, and Proteus mirabilis were similar. In the presence of urea, the survival of the wild-type H. pylori at pH 2 was significantly greater than that of the other organisms. Omeprazole (100 micrograms/mL) had a marked inhibitory effect on the survival of both wild-type and urease-negative H. pylori at low pH, and similar effects on E. coli, P. mirabilis, and Salmonella typhimurium.
CONCLUSIONS: Whereas survival of H. pylori below pH 4 is urease dependent, H. pylori uses non-urease-mediated mechanisms at or above pH 4. Omeprazole inhibits the survival of H. pylori at low pH through a mechanism independent of its effect on urease, an antibacterial effect that extends to other enteric bacteria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926527     DOI: 10.1016/0016-5085(94)90582-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

1.  Requirement of histidine kinases HP0165 and HP1364 for acid resistance in Helicobacter pylori.

Authors:  John T Loh; Timothy L Cover
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Hypersensitivity reaction to omeprazole in a patient treated for Helicobacter pylori.

Authors:  Sarah Anderson; Sarah Christensen
Journal:  Therap Adv Gastroenterol       Date:  2015-03       Impact factor: 4.409

3.  Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides.

Authors:  Menghua Xiong; Yan Bao; Xin Xu; Hua Wang; Zhiyuan Han; Zhiyu Wang; Yeqing Liu; Songyin Huang; Ziyuan Song; Jinjing Chen; Richard M Peek; Lichen Yin; Lin-Feng Chen; Jianjun Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-13       Impact factor: 11.205

4.  Unidentified intralesional and intracellular coccoid microorganism discovered in the young man with a diffuse erosive gastroduodenitis and multiple superficial ulcerations.

Authors:  Takayuki Okada; Graham Adkins
Journal:  BMJ Case Rep       Date:  2014-02-04

5.  Analysis of F1F0-ATPase from Helicobacter pylori.

Authors:  C C McGowan; T L Cover; M J Blaser
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

6.  Energetics of Helicobacter pylori and its implications for the mechanism of urease-dependent acid tolerance at pH 1.

Authors:  Kerstin Stingl; Eva-Maria Uhlemann; Roland Schmid; Karlheinz Altendorf; Evert P Bakker
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

Review 7.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

8.  Novel action of gastric proton pump inhibitor on suppression of Helicobacter pylori induced angiogenesis.

Authors:  M Yeo; D-K Kim; S U Han; J E Lee; Y B Kim; Y K Cho; J H Kim; S W Cho; K-B Hahm
Journal:  Gut       Date:  2005-08-26       Impact factor: 23.059

9.  Helicobacter pylori containing only cytoplasmic urease is susceptible to acid.

Authors:  P Krishnamurthy; M Parlow; J B Zitzer; N B Vakil; H L Mobley; M Levy; S H Phadnis; B E Dunn
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  Isolation of the Helicobacter pylori recA gene and involvement of the recA region in resistance to low pH.

Authors:  S A Thompson; M J Blaser
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.